As of 2024-12-14, the Relative Valuation of Avid Bioservices Inc (CDMO) is (70.44) USD. This relative valuation is based on P/E multiples. With the latest stock price at 12.34 USD, the upside of Avid Bioservices Inc based on Relative Valuation is -670.9%.
The range of the Relative Valuation is (78.68) - (73.19) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 34.4x - 37.4x | 35.9x |
| Forward P/E multiples | 19.4x - 32.0x | 25.7x |
| Fair Price | (78.68) - (73.19) | (70.44) |
| Upside | -737.6% - -693.1% | -670.9% |
| Date | P/E |
| 2024-12-13 | -5.40 |
| 2024-12-12 | -5.38 |
| 2024-12-11 | -5.35 |
| 2024-12-10 | -5.38 |
| 2024-12-09 | -5.36 |
| 2024-12-06 | -5.37 |
| 2024-12-05 | -5.37 |
| 2024-12-04 | -5.38 |
| 2024-12-03 | -5.39 |
| 2024-12-02 | -5.39 |
| 2024-11-29 | -5.37 |
| 2024-11-27 | -5.40 |
| 2024-11-26 | -5.39 |
| 2024-11-25 | -5.38 |
| 2024-11-22 | -5.38 |
| 2024-11-21 | -5.36 |
| 2024-11-20 | -5.34 |
| 2024-11-19 | -5.33 |
| 2024-11-18 | -5.32 |
| 2024-11-15 | -5.31 |
| 2024-11-14 | -5.22 |
| 2024-11-13 | -5.33 |
| 2024-11-12 | -5.35 |
| 2024-11-11 | -5.36 |
| 2024-11-08 | -5.36 |
| 2024-11-07 | -5.35 |
| 2024-11-06 | -4.80 |
| 2024-11-05 | -4.61 |
| 2024-11-04 | -4.52 |
| 2024-11-01 | -4.49 |
| 2024-10-31 | -4.35 |
| 2024-10-30 | -4.44 |
| 2024-10-29 | -4.45 |
| 2024-10-28 | -4.42 |
| 2024-10-25 | -4.37 |
| 2024-10-24 | -4.46 |
| 2024-10-23 | -4.53 |
| 2024-10-22 | -4.56 |
| 2024-10-21 | -4.39 |
| 2024-10-18 | -4.44 |
| 2024-10-17 | -4.44 |
| 2024-10-16 | -4.46 |
| 2024-10-15 | -4.49 |
| 2024-10-14 | -4.43 |
| 2024-10-11 | -4.51 |
| 2024-10-10 | -4.45 |
| 2024-10-09 | -4.53 |
| 2024-10-08 | -4.53 |
| 2024-10-07 | -4.58 |
| 2024-10-04 | -4.65 |